Eisen T - Search Results

1

Common variation at 2q22.3 (ZEB2) influences the risk of renal cancer.

Henrion M, Frampton M, Scelo G, Purdue M, Ye Y, Broderick P, Ritchie A, Kaplan R, Meade A, McKay J, Johansson M, Lathrop M, Larkin J, Rothman N, Wang Z, Chow WH, Stevens VL, Ryan Diver W, Gapstur SM, Albanes D, Virtamo J, Wu X, Brennan P, Chanock S, Eisen T, Houlston RS. Henrion M, et al. Among authors: eisen t. Hum Mol Genet. 2013 Feb 15;22(4):825-31. doi: 10.1093/hmg/dds489. Epub 2012 Nov 25. Hum Mol Genet. 2013. PMID: 23184150 Free PMC article.

2

Inherited variants in MYH are unlikely to contribute to the risk of lung carcinoma.

Al-Tassan N, Eisen T, Maynard J, Bridle H, Shah B, Fleischmann C, Sampson JR, Cheadle JP, Houlston RS. Al-Tassan N, et al. Among authors: eisen t. Hum Genet. 2004 Jan;114(2):207-10. doi: 10.1007/s00439-003-1033-2. Epub 2003 Oct 25. Hum Genet. 2004. PMID: 14579148

3

Case-control study of familial lung cancer risks in UK women.

Matakidou A, Eisen T, Bridle H, O'Brien M, Mutch R, Houlston RS. Matakidou A, et al. Among authors: eisen t. Int J Cancer. 2005 Sep 1;116(3):445-50. doi: 10.1002/ijc.21012. Int J Cancer. 2005. PMID: 15800943

4

Evaluation of xeroderma pigmentosum XPA, XPC, XPD, XPF, XPB, XPG and DDB2 genes in familial early-onset lung cancer predisposition.

Matakidou A, Eisen T, Fleischmann C, Bridle H, Houlston RS; GELCAPS Consortium. Matakidou A, et al. Among authors: eisen t. Int J Cancer. 2006 Aug 15;119(4):964-7. doi: 10.1002/ijc.21931. Int J Cancer. 2006. PMID: 16550608

5

Anti-alphaGal-dependent complement-mediated cytotoxicity in metastatic melanoma.

Larkin JM, Norsworthy PJ, A'Hern RP, Eisen TG, Gore ME, Porter CD. Larkin JM, et al. Melanoma Res. 2006 Apr;16(2):157-63. doi: 10.1097/01.cmr.0000200490.62723.b0. Melanoma Res. 2006. PMID: 16567971

6

Variants in the GH-IGF axis confer susceptibility to lung cancer.

Rudd MF, Webb EL, Matakidou A, Sellick GS, Williams RD, Bridle H, Eisen T, Houlston RS; GELCAPS Consortium. Rudd MF, et al. Among authors: eisen t. Genome Res. 2006 Jun;16(6):693-701. doi: 10.1101/gr.5120106. Genome Res. 2006. PMID: 16741161 Free PMC article.

7

Kinase inhibitors in the treatment of renal cell carcinoma.

Larkin JM, Eisen T. Larkin JM, et al. Among authors: eisen t. Crit Rev Oncol Hematol. 2006 Dec;60(3):216-26. doi: 10.1016/j.critrevonc.2006.06.008. Epub 2006 Jul 24. Crit Rev Oncol Hematol. 2006. PMID: 16860997 Review.

8

Lack of evidence that p53 Arg72Pro influences lung cancer prognosis: an analysis of survival in 619 female patients.

Matakidou A, El Galta R, Webb EL, Rudd MF, Bridle H, Eisen T, Houlston RS; GELCAPS Consortium. Matakidou A, et al. Among authors: eisen t. Lung Cancer. 2007 Aug;57(2):207-12. doi: 10.1016/j.lungcan.2007.02.021. Epub 2007 Apr 2. Lung Cancer. 2007. PMID: 17400332

9

Genetic variation in the DNA repair genes is predictive of outcome in lung cancer.

Matakidou A, el Galta R, Webb EL, Rudd MF, Bridle H; GELCAPS Consortium; Eisen T, Houlston RS. Matakidou A, et al. Among authors: eisen t. Hum Mol Genet. 2007 Oct 1;16(19):2333-40. doi: 10.1093/hmg/ddm190. Hum Mol Genet. 2007. PMID: 17855454

10

Renal cell carcinoma and the use of sorafenib.

Larkin JM, Eisen T. Larkin JM, et al. Among authors: eisen t. Ther Clin Risk Manag. 2006 Mar;2(1):87-98. Ther Clin Risk Manag. 2006. PMID: 18360584 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

248 results

Search Page

Filters